Literature DB >> 1787505

Low dose methotrexate treatment in systemic sclerosis.

F H van den Hoogen, A M Boerbooms, L B van de Putte, J J Rasker, W J van Venrooij.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1787505

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  5 in total

1.  The natural course of progressive systemic sclerosis patients with interstitial lung involvement.

Authors:  Musellim Benan; Ikitimur Hande; Ongen Gul
Journal:  Clin Rheumatol       Date:  2006-04-25       Impact factor: 2.980

Review 2.  Current therapy of systemic sclerosis (scleroderma).

Authors:  U Müller-Ladner; K Benning; B Lang
Journal:  Clin Investig       Date:  1993-04

3.  Methotrexate-related pulmonary complications in patients with rheumatoid arthritis: cluster of five cases in a period of three months.

Authors:  P Barrera; A Van Ede; R F Laan; P L Van Riel; A M Boerbooms; L B Van De Putte
Journal:  Ann Rheum Dis       Date:  1994-07       Impact factor: 19.103

Review 4.  Methotrexate-related pulmonary complications in rheumatoid arthritis.

Authors:  P Barrera; R F Laan; P L van Riel; P N Dekhuijzen; A M Boerbooms; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1994-07       Impact factor: 19.103

5.  Effects of methotrexate on glycosaminoglycan production by scleroderma fibroblasts in culture.

Authors:  F H van den Hoogen; P M van der Kraan; A M Boerbooms; W B van den Berg; H J van Lier; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1993-10       Impact factor: 19.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.